Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Reglagene
Hermosillo, Mexico
D
1-10 Employees
2018
Key takeaway
Reglagene is dedicated to advancing medical science, particularly in the treatment of brain cancers and diseases. They are developing a novel tubulin-targeting therapy that is designed to penetrate the blood-brain barrier, offering potential new hope for effective treatment options.
Reference
Core business
About — Reglagene | Transforming Tubulin Therapy for Brain Diseases
Reglagene is Transforming Tubulin Therapy for Brain Diseases. This began in November 2016 when Dr. Richard Austin engaged in a transformative discussion with Dr. Laurence Hurley and Dr. Vijay Gokhale, distinguished faculty members at the University of Arizona, who shared groundbreaking insights int
CHIPSA Hospital
Tijuana, Mexico
D
51-100 Employees
1997
Key takeaway
CHIPSA Hospital emphasizes its commitment to innovative and comprehensive cancer care, including treatments that may align with advancements in gene therapy. Their approach focuses on maximizing effective therapies and continuously enhancing patient care beyond traditional methods.
Reference
Core business
Lightbox – Stem Cell Treatments (Chic Smart Homepage) | CHIPSA Hospital: Gerson Therapy Center Cancer Treatment
Rehealth Stem Cells
Cancún, Mexico
D
11-50 Employees
2012
Key takeaway
Rehealth specializes in cell therapy, which is a promising approach for various medical conditions, potentially aligning with interests in innovative treatments like in vivo gene therapy. Their team of experts focuses on personalized therapeutic strategies, utilizing cell therapeutics to enhance the body's natural healing processes.
Reference
Core business
RE HEALTH - Regenerative Therapies
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Noxgen Biotech
Ecatepec de Morelos, Mexico
D
11-50 Employees
2015
Key takeaway
With a decade of experience in molecular diagnostics and genetics, Noxgen Biotech is dedicated to advancing innovation in the field of human health. They offer cutting-edge genetic testing that supports personalized medicine, making them a strategic partner in the development of biotechnological projects.
Reference
Core business
Laboratorio biotecnológico | Noxgen Biotech | México
Noxgen Biotech | Laboratorio de Biotecnología Donde Aplicamos Alta tecnología Genómica, Microbiológica y de Biología Molecular en Beneficio de la Salud Humana.
GSE Biomedical
Hermosillo, Mexico
D
1-10 Employees
2012
Key takeaway
GSE Biomedical is dedicated to enhancing lives through innovative medical technologies, with a team experienced in medical device design and biomedical engineering. Their focus on research and development may align with advancements in areas like in vivo gene therapy.
Reference
Product
GSE Biomedical | Portfolio
GSE Biomedical | International medical technology projects delivered successfully.
Inosan Biopharma
Mexico
D
51-100 Employees
2012
Key takeaway
Inosan Biopharma specializes in developing and distributing advanced antivenoms, highlighting their expertise in biological therapies that counteract venom effects from snakes, scorpions, and spiders. Their innovative approach and commitment to high manufacturing standards position them as a key player in providing critical treatments for venomous animal bites and stings.
Reference
Core business
THE ANTIVENOM COMPANY - Inosan Biopharmay
Oncovision
Mexico
D
51-100 Employees
2003
Key takeaway
Oncovision is a leading provider of innovative medical imaging devices that enhance the diagnosis and treatment of cancer. Their product line includes advanced technologies like the Sentinella intra-operative Gamma Camera and Mammi PET, which are crucial for visualizing and quantifying tumor activity.
Reference
Core business
About Us – Oncovision
Vitro SAB de CV
Monterrey, Mexico
D
10001+ Employees
1909
Key takeaway
The company, Vitro, is focused on research and development, which may be relevant to advancements in in vivo gene therapy.
Reference
Core business
Vitro - Research and Development
Vitro SAB de CV
Monterrey, Mexico
D
10001+ Employees
1909
Key takeaway
Vitro is focused on research and development, indicating their potential engagement in innovative therapies like in vivo gene therapy.
Reference
Core business
Vitro - Research and Development
Cohortias - A Julius Clinical Company
Monterrey, Mexico
D
11-50 Employees
2017
Key takeaway
Cohortias is a dedicated Clinical Research Organization (CRO) in Latin America that streamlines the clinical trial process for biotech and pharmaceutical companies, potentially benefiting those involved in in vivo gene therapy research. Their extensive network of clinical sites and commitment to high standards and efficient recruitment can enhance the development and execution of clinical trials in this area.
Reference
Service
Rescue Studies | Clinical Research in Latin America | Cohortias
Getting your trial back on track
Technologies which have been searched by others and may be interesting for you:
The In Vivo Gene Therapy industry in Mexico is influenced by several critical factors. Regulatory frameworks play a significant role, as the Mexican government, through the Federal Commission for Protection against Sanitary Risk (COFEPRIS), oversees the approval and monitoring of gene therapy products. Understanding these regulations is essential for compliance and successful market entry. Challenges include the need for substantial investment in research and development, as well as navigating clinical trial protocols, which can be time-consuming and costly. Despite these hurdles, Mexico presents numerous opportunities, including a growing demand for advanced therapies and a favorable demographic profile that supports clinical trials. Environmental concerns related to gene therapy, such as the potential impact of genetically modified organisms, require attention to ensure sustainable practices. The competitive landscape includes both local companies and international firms, making market analysis vital for identifying potential partners or competitors. Finally, the global relevance of the gene therapy market positions Mexico as a strategic location for research and development, particularly given its proximity to the United States and its emerging status in biopharmaceutical innovation. Engaging with local stakeholders and understanding market dynamics will be crucial for anyone seeking to navigate the In Vivo Gene Therapy sector in Mexico effectively.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Mexico |
| Amount of fitting manufacturers | 3 |
| Amount of suitable service providers | 9 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1909 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Consulting, Medical, Healthcare, Pharmaceuticals
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.